Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1706 vs EU Avastin in advanced non-squamous NSCLC
CTR20170799Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Oct 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of RPH-001 in Non-small cell lung cancer (NS-NSCLC), sponsored by Bio-Thera Solutions, Ltd.. Started Oct 2017; status: completed.
02
Drugs
RPH-001
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on CTR20170799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170799.